Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
54 Cards in this Set
- Front
- Back
Which class of drugs causes Veno-Occlusive Dz of the Liver?
|
Alkylating agents
|
|
MOA of Alkylating agents?
|
alkylate DNA and form Cross-links and strand breaks
|
|
cyclophospamide causes what unique adverse effect due to accumulated acrolein?
|
hemorrhagic cystitis
|
|
These drugs are good for Brain tumors because they are lipophilic and cross the BBB readily.
****************** |
Carmustine and Lomustine
|
|
Cisplatin uses of what type of cancer?
********************* |
Testicular, Ovarian, and bladder cancer
|
|
Cisplatin is active in what type of environments typically found in urine and inside of cells
|
low chloride environments
|
|
Cisplatin adverse effect in the CNS?
|
motor and sensory neuropathies and ototoxicity.
|
|
MOA of Methotrexate?
|
inhibits DHFR which blocks use of folate (antifolate)
|
|
Methotrexate use?
************ |
leukemia and lymphoma, breast CA, Psoriasis and RA
|
|
Too much Methotrexate can cause the need for what?
|
Lecovorin Rescue to replinish the intracellular pool of tetrahydrofolate cofactors.
|
|
Methotrexate Adverse effects?
|
GI ulcers, mucusitis, BMD
|
|
What drug topically treats basal cell Carcinoma?
Also treats breast and colorectal cancer ********************* |
5-Fluorouracil
|
|
MOA of 5-Fluorouracil?
|
decrease TTP and inhibit DNA synthesis
|
|
Uses of Cytarabine
|
Hematological CA:
AML, ALL, and non-Hodgkin's lymphoma |
|
Cytarabine must be converted to what before it is active?
|
ara-C
|
|
Uses of Gemcitabine
|
breast, nonsmall cell lung CA, pancreatic, and ovarian
|
|
6-Mercaptopurine & 6- thioguanine uses?
**************** |
ALL, AML, CML
|
|
6-Mercaptopurine & 6- thioguanine MOA?
|
inhibit synthesis of purine nucleotides
|
|
6-Mercaptopurine & 6- thioguanine when used with allopurinol what must be done?
|
decrease dosage b/c the 6-...drugs are metabolized by Xanthine Oxidase which is what allopurinol blocks.
|
|
Vincristine and Vinblastine MOA?
|
antimitotic by binding to Beta-tubulin and inhibiting microtubule polymerization
|
|
Vincristine uses?
******************** |
**DOC** to induce remission in Lymphocytic leukemia
(leukemias and lymphomas) |
|
Vincristine intrathecally???
|
FATAL
|
|
Vinblastine uses?
|
Hodgkin's and non-Hodgkin's Lymphomas, testicular CA, Breast CA, Kaposi's Sarcoma
|
|
Paclitaxel MOA
|
Keeps cell stuck in metaphase by binding to tubulin and not allowing them to break down, activates apoptosis
|
|
Doxetaxel MOA
|
Keeps cell stuck in metaphase by binding to tubulin and not allowing them to break down, activates apoptosis
|
|
Paclitaxel Uses
|
Breast and Ovarian CA
Non-small cell Lung CA |
|
Docetaxel Uses
|
breast CA, nonsmall cell lung, prostate CA, gastric adenocarcinoma, squamous cell head & neck CA
|
|
Etoposide MOA
|
inhibits topoisomerase II causing DNA damage.
|
|
Etoposide Uses
|
refractory testicular tumors and SMALL CELL LUNG CANCER
|
|
Topotecan and Irinotecan
MOA: Uses: |
MOA: Topoisomerase I inhibitors
Uses: Topotecan- Ovarian and Small cell lung CA Irinotecan- Metastatic Colon CA |
|
Irinotecan AE:
|
Diarrhea and BMD
|
|
Dactinomycin MOA
|
Blocks DNA/RNA synthesis
|
|
which 2 drugs are powerful iron chelators?
|
Doxorubicin and Daunorubicin
|
|
Uses of Daunorubicin
|
ALL and ANLL
|
|
Doxorubicin and Daunorubicin special toxicity
|
Cardiotoxicity because of generation of free radicals.
|
|
Bleomycin uses
|
Lymphomas, squamous cell carcinomas, and head/neck cancers
|
|
Bleomycin special toxicity
|
Pulmonary toxicity that starts as pneumonitis and progresses to Pulmonary fibrosis
|
|
L-Asparginase use
******************** |
Standard agent for treating lymphocytic leukemias including ALL
|
|
L-Asparginase adverse effects:
|
Anaphylaxis, Coagulopathy, CNS effects, Thrombosis especially in the sagittal sinus, pancreatitis, glucose intolerance
|
|
Prednisone MOA:
|
suppress immune system
|
|
Prednisone AE:
|
cushing like syndromes, osteoporosis
|
|
Tamoxifen MOA:
|
non-steroidal anti-estrogen
|
|
Tamoxifen Use:
******************** |
Breast cancer
best results in ER+ tumors also useful in osteoporosis b/c it increases bone mineralization |
|
Anastrozole MOA:
****************** |
Competitively inhibit adrenal synthesis of steroids and inhibit conversion of androgens to estrogens. Use this drug when Tamoxifen isn't working
|
|
Bortezomib Use
********************* |
Multiple Myeloma
|
|
Bortezomib MOA:
|
inhibits proteosome
|
|
Imatinib MOA
|
inhibits Bcr-Abl tyrosine kinase
|
|
Imatinib Use:
************** |
CML characterized by the Philadelphia chromosome
|
|
Trastuzumab MOA
|
monoclonal Ab to HER-2 receptor
|
|
Trastuzumab use
***************** |
aggressive ER(-) breast CA
|
|
Bevacizumab MOA
|
Blocks VEGF and cannot form vascular blood supply to tumor
|
|
Bevacizumab uses:
|
Metastatic colorectal CA
|
|
Hydroxyurea MOA
|
inhibits ribonucleotide reductase and inhibits DNA synthesis
|
|
Hydroxyurea Uses
|
melanoma, CML, ovarian CA
|